Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-Angle Glaucoma (OAG).
Phase of Trial: Phase IV
Latest Information Update: 05 Jan 2012
At a glance
- Drugs Bimatoprost; Latanoprost; Travoprost
- Indications Glaucoma; Ocular hypertension
- Focus Therapeutic Use
- Sponsors Allergan
- 05 Jan 2012 Actual patient number is 1099 according to ClinicalTrials.gov.
- 05 Jan 2012 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 05 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.